BECTON, DICKINSON AND COMPANY Interest Costs Capitalized
BECTON, DICKINSON AND COMPANY (BDX) reported Interest Costs Capitalized of $62.00 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestCostsCapitalized · last filed 2025-11-25
- BECTON, DICKINSON AND COMPANY interest costs capitalized for fiscal 2025 was $62.00M, a 8.77% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY interest costs capitalized for fiscal 2024 was $57.00M, a 11.76% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY interest costs capitalized for fiscal 2023 was $51.00M, a 10.87% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY interest costs capitalized for fiscal 2022 was $46.00M, a 4.55% increase from fiscal 2021.
| Period end | Interest Costs Capitalized 12 month | Interest Costs Capitalized 12 month as first filed |
|---|---|---|
| 2025-09-30 | $62.00M 10-K · filed 2025-11-25 | |
| 2024-09-30 | $57.00M 10-K · filed 2025-11-25 | |
| 2023-09-30 | $51.00M 10-K · filed 2025-11-25 | |
| 2022-09-30 | $46.00M 10-K · filed 2024-11-27 | |
| 2021-09-30 | $44.00M 10-K · filed 2023-11-21 | |
| 2020-09-30 | $43.00M 10-K · filed 2022-11-22 | |
| 2019-09-30 | $44.00M 10-K · filed 2021-11-24 | |
| 2018-09-30 | $42.00M 10-K · filed 2020-11-25 | |
| 2017-09-30 | $32.00M 10-K · filed 2019-11-27 | |
| 2016-09-30 | $30.00M 10-K · filed 2018-11-21 | |
| 2015-09-30 | $30.00M 10-K · filed 2017-11-22 | |
| 2014-09-30 | $32.00M 10-K · filed 2016-11-23 | |
| 2013-09-30 | $33.00M 10-K · filed 2015-11-25 | |
| 2012-09-30 | $34.00M 8-K · filed 2015-03-13 | $34.35M 10-K · filed 2012-11-21 |
| 2011-09-30 | $38.00M 10-K · filed 2013-11-27 | $37.93M 10-K · filed 2011-11-23 |
| 2010-09-30 | $36.44M 10-K · filed 2012-11-21 | |
| 2009-09-30 | $29.36M 10-K · filed 2011-11-23 | |
| 2008-09-30 | $29.86M 10-K · filed 2010-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |